| Report ID | 282580 |
| Drug Identification Number | 02537893 |
| Brand name | ACETAZOLAMIDE FOR INJECTION USP |
| Common or Proper name | ACETAZOLAMIDE FOR INJECTION USP 500 MG/VIAL |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETAZOLAMIDE |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1X1 VIAL |
| ATC code | S01EC |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-05-01 |
| Actual start date | |
| Estimated end date | 2026-07-31 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-04-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 400 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-09 | French | Compare |
| v1 | 2026-04-09 | English | Compare |
Showing 1 to 2 of 2